Who Owns EFTRW?
EFFECTOR THERAPEUTICS INC — Institutional Ownership & 13F Holdings
$0.00
+0.00 (+0.00%)
Market Cap
—
Shares Outstanding
—
Institutional Holders
12
Total Inst. Value
$2.4B
% of Float Held
—
QoQ Holder Change
—
Institutional data as of Q1 2024
Top 10 Institutional Holders(Q1 2024)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.4B | 16,794 |
| 2 | ARISTEIA CAPITAL, L.L.C. | $183K | 1,333,446 |
| 3 | GOLDMAN SACHS GROUP INC | $85K | 630,539 |
| 4 | WHITEBOX ADVISORS LLC | $40K | 298,145 |
| 5 | MMCAP International Inc. SPC | $20K | 145,941 |
| 6 | Parallel Advisors, LLC | $9K | 64,166 |
| 7 | TENOR CAPITAL MANAGEMENT Co., L.P. | $5K | 33,333 |
| 8 | WOLVERINE ASSET MANAGEMENT LLC | $1K | 9,829 |
| 9 | UBS Group AG | $87 | 644 |
| 10 | Tower Research Capital LLC (TRC) | $3 | 23 |
Frequently Asked Questions
How many institutional investors hold EFTRW?
As of Q1 2024, 12 institutional investors report holding EFTRW (EFFECTOR THERAPEUTICS INC) in their 13F filings.
Which hedge fund owns the most EFTRW?
The largest institutional holder of EFTRW is SUSQUEHANNA INTERNATIONAL GROUP, LLP with $2.4B in shares.
Are institutions buying or selling EFTRW?
This quarter, 12 institutions opened new positions in EFTRW and 0 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.